Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois

Alex Rains, Mary York, Rebecca Bolinski, Jerel Ezell, Lawrence J Ouellet, Wiley D Jenkins, Mai T Pho, Alex Rains, Mary York, Rebecca Bolinski, Jerel Ezell, Lawrence J Ouellet, Wiley D Jenkins, Mai T Pho

Abstract

Background: Chronic health conditions associated with long-term drug use may pose additional risks to people who use drugs (PWUD) when coupled with COVID-19 infection. Despite this, PWUD, especially those living in rural areas, may be less likely to seek out health services. Previous research has highlighted the increased disease burden of COVID-19 among PWUD. Our manuscript supplements this literature by exploring unique attitudes of PWUD living in rural areas toward the pandemic, COVID-19 vaccination, and the role of harm reduction (HR) organizations in raising health awareness among PWUD.

Methods: Semi-structured interviews were conducted with 20 PWUD living in rural southern Illinois. Audio recordings were professionally transcribed. A preliminary codebook was created based on interview domains. Two trained coders conducted iterative coding of the transcripts, and new codes were added through line-by-line coding and thematic grouping.

Results: Twenty participants (45% female, mean age of 38) completed interviews between June and November 2021. Participants reported negative impacts of the pandemic on mental health, financial wellbeing, and drug quality. However, the health impacts of COVID-19 were often described as less concerning than its impacts on these other aspects of life. Many expressed doubt in the severity of COVID-19 infection. Among the 16 unvaccinated participants who reported receiving most of their information from the internet or word of mouth, uncertainty about vaccine contents and distrust of healthcare and government institutions engendered wariness of the vaccination. Distrust of healthcare providers was related to past stigmatization and judgement, but did not extend to the local HR organization, which was unanimously endorsed as a positive institution. Among participants who did not access services directly from the HR organization, secondary distribution of HR supplies by other PWUD was a universally cited form of health maintenance. Participants expressed interest in low-threshold healthcare, including COVID-19 vaccination, should it be offered in the local HR organization's office and mobile units.

Conclusion: COVID-19 and related public health measures have affected this community in numerous ways. Integrating healthcare services into harm reduction infrastructures and mobilizing secondary distributors of supplies may promote greater engagement with vaccination programs and other healthcare services.

Trial number: NCT04427202.

Keywords: Access to health services; COVID-19; Harm reduction; Low-threshold healthcare; People who use drugs; Qualitative analysis; Rural; Secondary distribution.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

References

    1. Drug overdose death statistics [2022]: Opioids, fentanyl & more. NCDAS. . Published 6 April 2022.
    1. Degenhardt L, Peacock A, Colledge S, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017 doi: 10.1016/s2214-109x(17)30375-3.
    1. Noonan R. Rural America in crisis: the changing opioid overdose epidemic. Centers for Disease Control and Prevention. . Published 28 Nov 2017.
    1. Establishing a Syringe Services Program in Rural America. National Harm Reduction Coalition. . Published 8 Sept 2020.
    1. Walters S. Covid-19 and people who use drugs—a commentary. Health Behav Policy Rev. 2020;7(5):489–497. doi: 10.14485/hbpr.7.5.11.
    1. Products—vital statistics rapid release—provisional drug overdose data. Centers for Disease Control and Prevention. . Published 13 Oct 2021.
    1. Stack E, Leichtling G, Larsen JE, et al. The impacts of covid-19 on mental health, substance use, and overdose concerns of people who use drugs in rural communities. J Addict Med. 2020;15(5):383–389. doi: 10.1097/adm.0000000000000770.
    1. Radfar SR, De Jong CA, Farhoudian A, et al. Reorganization of substance use treatment and harm reduction services during the COVID-19 pandemic: a global survey. Front Psych. 2021 doi: 10.3389/fpsyt.2021.639393.
    1. Innovation and resilience in times of crisis (part 2): The response to .... July 2021. .
    1. Rural Emergency Hospital policy brief—rural health. Findings After Wave 1. 2022. .
    1. Dror AA, Eisenbach N, Taiber S, et al. Vaccine hesitancy: the next challenge in the fight against COVID-19. Eur J Epidemiol. 2020;35(8):775–779. doi: 10.1007/s10654-020-00671-y.
    1. Gale J, Knudson A, Meit M, Popat S. Ensuring an equitable distribution of COVID-19 vaccines in rural communities. National Rural Health Association.
    1. Spleen AM, Lengerich EJ, Camacho FT, Vanderpool RC. Health care avoidance among rural populations: results from a nationally representative survey. J Rural Health. 2014;30(1):79–88. doi: 10.1111/jrh.12032.
    1. Ellis K, Walters S, Friedman SR, et al. Breaching trust: a qualitative study of healthcare experiences of people who use drugs in a rural setting. Front Sociol. 2020 doi: 10.3389/fsoc.2020.593925.
    1. Snead J, Downing M, Lorvick J, et al. Secondary syringe exchange among injection drug users. J Urban Health. 2003;80(2):330–348. doi: 10.1093/jurban/jtg035.
    1. Distressed counties and parishes. Delta Regional Authority. 2021. .
    1. Illinois coronavirus map: Tracking the trends. Mayo Clinic. 2022. .
    1. Vaccine data. Illinois Department of Public Health. 2022. .
    1. The state of Rural Health in Illinois. Illinois Rural Health Summit Planning Committee. 2022. .
    1. The opioid crisis in Illinois: data and the state’s response. Illinois DHS. 2022. .
    1. COVID-19 and the rural opioid epidemic: recommendations to improve health in Illinois. SIU Medicine Department of Population Science and Policy. . November 2021.
    1. ROI Research Consortium Studies. Rural opioid initiative. . Published 2022. Accessed 18 May 2022.
    1. Constructs. The Consolidated Framework for Implementation Research. .
    1. Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997;44(2):174–199. doi: 10.2307/3096941.
    1. Charmaz K, Belgrave LL. Thinking about data with grounded theory. Qual Inq. 2018;25(8):743–753. doi: 10.1177/1077800418809455.
    1. Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349–357. doi: 10.1093/intqhc/mzm042.
    1. Edland-Gryt M, Sketvedt AH. Thresholds in a low-threshold setting: an empirical study of barriers in a centre for people with drug problems and mental health disorders. Int J Drug Policy. 2013;24(3):257–264. doi: 10.1016/j.drugpo.2012.08.002.
    1. Stack E, Leichtling G, Larsen JE, et al. The impacts of COVID-19 on mental health, substance use, and overdose concerns of people who use drugs in rural communities. J Addict Med. 2020 doi: 10.1097/ADM.0000000000000770.
    1. Seaman A, Leichtling G, Stack E, et al. Harm reduction and adaptations among PWUD in rural Oregon during COVID-19. AIDS Behav. 2021;25(5):1331–1339. doi: 10.1007/s10461-020-03141-4.
    1. Perri M, Kaminski N, Bonn M, et al. A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone. Harm Reduct J. 2021;18(1):85. doi: 10.1186/s12954-021-00530-3.
    1. Ali F, Russell C, Nafeh F, Rehm J, LeBlanc S, Elton-Marshall T. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: a national qualitative assessment in Canada. Int J Drug Policy. 2021;93:103237. doi: 10.1016/j.drugpo.2021.103237.
    1. Ellis K, Walters S, Friedman SR, et al. Breaching trust: a qualitative study of healthcare experiences of people who use drugs in a rural setting. Front Sociol. 2020;5:593925. doi: 10.3389/fsoc.2020.593925.
    1. Jenkins WD, Bolinski R, Bresett J, Van Ham B, Fletcher S, Walters S, Friedman SR, Ezell JM, Pho MT, Schneider J, Ouellet L. COVID-19 during the opioid epidemic—exacerbation of stigma and vulnerabilities. J Rural Health. 2021;37:172–174. doi: 10.1111/jrh.12442.
    1. Needle RH, Burrows D, Friedman SR, Dorabjee J, Touzé G, Badrieva L, Grund JC, Kumar MS, Nigro L, Manning G, Latkin C. Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. Int J Drug Policy. 2005;16S:S45–S57. doi: 10.1016/j.drugpo.2005.02.009.
    1. Wodak A, Cooney A. Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users. Geneva: World Health Organization; 2005.
    1. Kennedy MC, Karamouzian M, Kerr T. Public health and public order outcomes associated with supervised drug consumption facilities: a systematic review. Curr HIV/AIDS Rep. 2017;14:161–183. doi: 10.1007/s11904-017-0363-y.
    1. Temesgen ZM, DeSimone DC, Mahmood M, Libertin CR, Varatharaj Palraj BR, Berbari EF. Health care after the COVID-19 pandemic and the influence of telemedicine. Mayo Clin Proc. 2020;95(9S):S66–S68. doi: 10.1016/j.mayocp.2020.06.052.
    1. Perri M, Guta A, Gagnon M, et al. Developing a digital health strategy for people who use drugs: lessons from COVID-19. Digital Health. 2021 doi: 10.1177/20552076211028404.
    1. Patel SY, Mehrotra A. The surge of telehealth during the pandemic is exacerbating urban-rural disparities in access to mental health care: health affairs forefront. Health Aff. 2021 doi: 10.1377/forefront.20211004.155145.
    1. Craine N, Hickman M, Parry JV, Smith J, McDonald T, Lyons M. Characteristics of injecting drug users accessing different types of needle and syringe programme or using secondary distribution. J Public Health. 2010;32(3):328–335. doi: 10.1093/pubmed/fdp131.
    1. Sokol R, Fisher E. Peer support for the hardly reached: a systematic review. Am J Public Health. 2016;106:e1–e8. doi: 10.2105/AJPH.2016.303180.
    1. Crawford S, Bath N. Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection. Clin Infect Dis. 2013;57(suppl_2):S75–S79. doi: 10.1093/cid/cit297.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir